agilon health, inc. (NYSE:AGL) Given Consensus Rating of “Hold” by Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned a consensus recommendation of “Hold” from the twenty ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $8.03.

Several brokerages recently issued reports on AGL. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft cut their target price on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a research note on Wednesday, October 2nd. Evercore ISI cut their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Finally, Benchmark restated a “buy” rating and set a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th.

Insider Activity at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of AGL. Arizona State Retirement System grew its holdings in agilon health by 2.5% during the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after acquiring an additional 2,070 shares during the period. Swiss National Bank grew its holdings in agilon health by 0.6% during the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after acquiring an additional 3,400 shares during the period. J.Safra Asset Management Corp grew its holdings in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares during the period. Neo Ivy Capital Management acquired a new stake in agilon health during the 4th quarter worth about $47,000. Finally, Renaissance Capital LLC grew its holdings in agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock worth $1,166,000 after acquiring an additional 5,551 shares during the period.

agilon health Price Performance

agilon health stock opened at $3.32 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of -4.74 and a beta of 0.54. The stock’s 50 day moving average is $4.01 and its 200-day moving average is $5.27. agilon health has a 12 month low of $2.99 and a 12 month high of $20.37.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). The business had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.04) earnings per share. Equities research analysts expect that agilon health will post -0.32 EPS for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.